Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite severe hyperlipidemia, GSD Ia patients show limited atherogenesis compared to age-and-gender matched controls. Employing a GSD Ia mouse model that resembles the severe hyperlipidemia in patients, we here found increased atherogenesis in GSD Ia. These data provide a rationale for investigating atherogenesis in GSD Ia in a larger patient cohort.</p
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...